InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market – (By Product Type (Synthetic Fabric Graft, Stent-graft), By Age Group (Adult, Geriatric, Pediatric), By Material (Polymer, Metal), By Aortic Length (Above 50 mm, Above 100 mm, By End-User (Hospital, Ambulatory Surgical Centers (ASCs), Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Endovascular Abdominal Aortic Aneurysm Repair Devices Market is valued at US$ 2.43 Bn in 2023, and it is expected to reach US$ 3.53 Bn by 2031, with a CAGR of 4.9% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2400
Endovascular devices used in the treatment of abdominal aortic aneurysms (AAA) have revolutionized clinical approaches by offering a minimally invasive alternative to conventional open surgery. These devices typically consist of a fabric-based graft supported by a metallic stent framework, which is deployed within the aneurysmal segment of the aorta to redirect blood flow and relieve pressure on the weakened vessel wall, thereby mitigating the risk of rupture. The increasing incidence of abdominal aortic aneurysms, along with continual improvements in endovascular techniques, is a major driver of market expansion.
Endovascular aneurysm repair (EVAR) has emerged as the preferred therapeutic modality due to its substantial benefits over open surgical procedures. These advantages include reduced hospitalization periods, accelerated patient recovery, and enhanced clinical outcomes. As a result, EVAR is now widely regarded as the standard of care for AAA management.